Sponsored

Electronic Health Data Security is an Industry That Could Potentially Grow to Around $25.5 Billion(1)

Undervalued and Cutting-edge Ehave Inc. (OTC:EHVVF) Could Be Well Positioned to Benefit From This

News Release:
Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression

Global big data in healthcare was approximately a $14.7 billion market in 2018 and could potentially grow at a CAGR of around 20% to reach $42.8 billion over the next four years.(5)

Much of this can be attributed to the increased adoption of Electronic Health Records and the government’s interest in adopting a broadened healthcare information system. As reported by Reportlinker, “..increasing government funding and expenditure for the development of healthcare IT solutions is promoting the adoption of electronic health records, globally.” (6)

Additionally, the increased adoption of mobile health apps and wearable devices is further driving the demand for big data needs in healthcare.(7)

However, with these growing needs for big data in healthcare, the need to potentially meet a massive security challenge has been created. Because of this, the market for electronic health records security could be worth around $25.5 billion(1). This is where undervalued and cutting-edge Ehave Inc. (OTC:EHVVF) could be well positioned.

Ehave, Inc. (OTC:EHVVF) is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Its primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes.

The Top Reasons to Consider Ehave, Inc. (OTC:EHVVF)

  1. Ehave (OTC:EHVVF) is helping to meet the challenge of electronic health records security in a market potentially worth around $25.5 billion.(1)
  2. Ehave recently partnered with BurstIQ to deploy its Dashboard over BurstIQ’s blockchain network to leading healthcare organizations in the U.S.(2)
  3. Ehave also recently partnered with tech platform, Medchart to allow medical professionals to easily transfer medical records while allowing patients to own their data(3)
  4. Ehave just announced plans to enter the $30 billion patient medical record industry(4)
  5. Ehave will enter the $6.38 billion telepsychiatry industry with Active Doctors(4)
  6. Ehave just entered into a licensing agreement to license a complete suite of telemedicine solutions from Activ Doctors Online.(4)
  7. Ehave announced its foray into the growing psychedelics market on December 12 with its KetaDASH platform(14)– an Intravenous (IV) based, home delivery service for patients who have been prescribed KT. The psychedelic drugs market could grow to around $6.85 billion by 2027 at a CAGR of around 16.3%(13)

Ehave (OTC:EHVVF)- Showing Strong Returns, Strong Technicals, and Strong Growth Potential

Shares of Ehave (OTC:EHVVF) are trading around only $0.13 a share. However, there is momentum behind the company due to its positioning in areas of great demand and growth potential.

As a nano-cap stock with a market cap of only around $6.815 million(15), only around 52.023 million shares outstanding(16), and an approximate 78.8% float shares to outstanding shares ratio(17), Ehave appears to perform strongly whenever there is strong sentiment or good news. For example, by mid-day on December 22nd, the stock increased nearly 30%(18).

Additionally, ever since EVHFF announced its foray into the growing psychedelics market on December 12 with its KetaDASH platform(14), the stock has seen a return of approximately 176.42%(19).

Additionally, since the stock hit a 1-month low of approximately $.025 a share on December 3rd, the stock has seen a return of nearly 593.88%(20).

It is no wonder then that the stock appears to have strong short-term, medium-term, and long-term technical indicators, including the 20 Day Moving Average, 20-50 Day MACD Oscillator, 20-100 Day MACD Oscillator, 50 Day Moving Average, 100 Day Moving Average, and 150 Day Moving Average.

Ehave’s Solutions Appear to Fill Crucial Needs in Cutting-edge Ways

Along with providing digital therapeutics that appear to deliver evidence-based therapeutic interventions to healthcare patients, Ehave recently partnered with BurstIQ to deploy its Ehave Dashboard over BurstIQ’s blockchain network. With this partnership, this solution is expected to be deployed to leading healthcare organizations across the United States.

The Ehave Dashboard is a data driven platform that has been strategically developed to provide better communication among medical practitioners and health care providers.

This cloud based platform claims to deliver critical features and capabilities to healthcare providers, all while enabling seamless integrations with everything from electronic health records to telehealth providers.

This aggregation of data and information into one application appears to be effective in streamlining the healthcare process for both patients and providers.

Now, together with BurstIQ further developing the blockchain capabilities of this platform, the Ehave Dashboard appears to have the ability to segment data on-chain. This could allow developers, clinicians, researchers, doctors, hospitals, universities and, ultimately, prescribers of psychedelic therapies, to provide life-changing solutions to patients.

But this is only one part of Ehave’s story.

Major Partnerships Could Potentially Drive Significant Growth

Ehave appears to be working on partnerships and licensing deals that could leverage the Ehave Dashboard to create more data points than most competitors in the market.

Outside of its strategic partnership with BurstIQ, other potentially game-changing partnerships include:

MedChart

MedChart is a digital health company whose mission appears to change the way anyone interacts with their health data. The company claims to make it easier for patients to own their medical records, and in turn, receive the best care possible.

By permitting patients to own their own records, medical professionals and even psychedelic researchers can begin working with patients to create biomarkers on how they can live a longer healthier life, as well as discovering what treatments appear to be most effective.

At the moment, over approximately 16.1 million American adults have major depression(21). Treatment resistant depression can commonly occur in up to approximately 30% of this patient population(22).

Since major pharmaceutical companies appear not to develop drugs for these patients, the Ehave Dashboard could potentially aggregate data from this patient population and provide data to drug developers for clinical trials. This data could also potentially help insurers route patients to potential treatment providers that can possibly help them the most.(10)

Activ Doctors Online

Ehave recently entered into a licensing agreement with Activ Doctors Online. Under this agreement, Ehave aims to license a complete suite of telemedicine solutions from Activ Doctors. The agreement also claims to aid mental health patients in requesting an online consultation, obtaining a second medical opinion, and providing access to their complete medical history from their computer or mobile device.

This agreement will apparently allow the company to expand into the Medical Second Opinion market, which according to Reportlinker, could be a market worth around $10.7 billion by 2027. At the moment, this market is valued at around $3.2 billion.(11)

Additionally, according to Ehave CEO Ben Kaplan:

“We have seen a tremendous shift in the demand for virtual care, and we believe our society is on the cusp of a paradigm shift for the way healthcare is performed in our healthcare system. Under the terms of this licensing agreement we will be able to provide the technology that allows patients to connect with their mental healthcare providers remotely. This is a service that has seen a tremendous increase in demand as a result of the Covid-19 outbreak.”(12)

MyLifeID

The MyLifeID Pocket Cloud appears to be a fully-encrypted, virtually indestructible portable storage device specifically created to carry sensitive health and medical data. This device claims to be specifically designed for convenience and ease-of-use, and appears to be no larger than a credit card. The device’s slim profile could enable it to fit in a wallet so it can be quickly retrieved in case of an emergency.

Ehave’s Most Recent Foray Into the Potentially Lucrative Psychedelics Market

Ehave announced its foray into the growing psychedelics market on December 12 with its KetaDASH platform(14)– an Intravenous (IV) based, home delivery service for patients who have been prescribed KT. The psychedelic drugs market could grow to around $6.85 billion by 2027 at a CAGR of around 16.3%(13)

To make this venture happen, Ehave, Inc. acquired the tangible and intangible assets of IV therapy company CureDash. CureDash currently operates an IV delivery platform that could seemingly become the backbone of KetaDASH.

Ehave claims that its KetaDASH platform could provide a platform for medical practitioners to administer KT intravenously to patients at home. Although KT has not yet been approved by the FDA to treat depression, clinical studies are looking into the sedative as a potential treatment for major depression. Currently, KT is used to help ease pain, aid in the efficacy of sedatives at lower doses, and lessen the amount of potentially addictive pain medication required after certain medical procedures.

Ehave claims that its KetaDASH platform could include software, staffing, protocols, and equipment. Ehave also used its dashboard technology for KetaDASH in order to create an ecosystem where both clients and practitioners can get detailed insight on how the KT therapy is working. Ehave also claims that patients will be able to create a profile, check availability of administering nurses, and schedule appointments.

Ehave, Inc. (OTC:EHVVF) is Led by a Strong Team of Experienced Experts

The most successful companies are usually led by a knowledgeable and experienced management team, full of high character and high quality. Ehave, Inc. (OTC:EHVVF) certainly appears to have that and then some.

BEN KAPLAN
Chief Executive Officer

Ben Kaplan has served as Ehav’s CEO for the past 16 months. He has also served as Chairman since June 2020.

Ben is an entrepreneur at heart and has worked for over 20 years in the financial sector. He is an investor in a multitude of public and private companies focused on international growth. He has also conducted various investment activities out of New York City, and also invested in iconic Miami restaurant chain Roasters & Toasters in 2005.

Ben became a founding member of Kaya Jamaica Inc. in 2014- the largest green leaf company in the Caribbean (GROWKAYA.com). Ben still sits on the Board to this day.

In 2014, Ben also became one of the first investors in Surna, a global HVAC company that provides engineering and build-outs for high technology facilities.

Ben is also one of the founders of Kalytera, an Israeli botanical-based Pharma company researching various cures for numerous illnesses, including a Phase 2 trial for a GVHD (graft versus host disease) cure.

In 2018, Ben acquired Stemtech.com, a multilevel company showing a 30k strong sales force and operating in over 20 countries. Ben sits on the board and brought the company out of bankruptcy with a group of investors.

Ben also led a group of investors to form a partnership with Sensi Magazine in 2018.

ALFRED FARRINGTON
Chief Information Officer

Alfred joined Ehave in 2019 and brings over 20 years of technology, software architecture, and innovation experience in healthcare, data analytics, embedded systems, distributed systems, and gaming. Alfred’s most recent experience includes the position of software architect for the Concussion Monitoring System working with the University of Miami Concussion Facility.

Alfred was also recently a Director of IT at Immunity, Inc., responsible for architecting and designing a next generation platform to train Cybersecurity students for corporations.

Prior to these positions, Alfred designed and implemented the next generation network and analytic tools for Priority Networks.

DR. RUSSELL SCHACHAR M.D., FRCPC
Chief Medical Officer

Russell has been with the company since 2013. Russell was instrumental in our development activity with the Hospital for Sick Children in Toronto. Russell trained in medicine at the University of Toronto and in psychiatry at McMaster University in Hamilton, Ontario. Following this, he completed post-doctoral training during a fellowship at the University of London, England under the supervision of Professor Sir Michael Rutter. Motivated by a desire to advance the understanding of mental illness in youth, Mr. Schachar returned to SickKids, a hospital for sick children, where he initiated an acclaimed clinical-research program in Neuropsychiatry and set up a research laboratory.

DR. NITHIN KRISHNA
Medical Advisory Board

Dr. Krishna is currently in private practice at Psych Associates of Maryland. Psych Associates specializes in behavioral health services, including psychological testing and neuropsychological testing for a variety of disorders, including ADHD, brain injuries and head trauma, and memory problems. He boasts an extensive publication list and an impressive resume of original scientific findings.

Dr. Krishna completed his postdoctoral program at the University of Maryland School of Medicine, Maryland Psychiatric Research Center in Baltimore, Maryland continuing on through the University of Maryland/Sheppard Pratt Psychiatry Residency Training Program research track. Dr. Krishna is board certified by the American Board of Psychiatry and Neurology. In addition to his work as a clinician, he conducts research in psychiatry and neuroscience with expertise in genetics, electroencephalogram (EEG), schizophrenia, psychotic disorders, suicide and cranial electric stimulation.

VICTOR S. DORODNY, MD, PHD, MPH
Medical Advisory Board

Dr. Dorodny was one of the creators of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). He has served on the Advisory Board of the Association of Medical Director of Information Systems and is the Past President of the Western Division of the National Association of Managed Care Physicians. Dr. Dorodny has served in an executive capacity of several companies where he has held the title of Chief Medical Information Officer, Chief Scientific Advisor, and Chief Medical Officer. As a world renowned speaker, he has spoken at hearings in front of Congress, the California Senate Judiciary Committee, and the FDA-Pharmaceutical Services and Information Exchange. Over the course of his esteemed 45 year medical career, Dr. Dorodny has also been a speaker at dozens of medical conferences. In addition to his impressive medical background, Dr. Dorodny was a pioneer in the telemedicine industry, serving as CMO & Global Practice Leader for US Telemedicine from 2006 to 2009. He received his advanced medical degrees from the University of Odessa Medical School, Albert Einstein College of Medicine, and the University of Southern California.

The Top Reasons to Consider Ehave, Inc. (OTC:EHVVF)

  1. Ehave (OTC:EHVVF) is helping to meet the challenge of electronic health records security in a market potentially worth around $25.5 billion.(1)
  2. Ehave recently partnered with BurstIQ to deploy its Dashboard over BurstIQ’s blockchain network to leading healthcare organizations in the U.S.(2)
  3. Ehave also recently partnered with tech platform, Medchart to allow medical professionals to easily transfer medical records while allowing patients to own their data(3)
  4. Ehave just announced plans to enter the $30 billion patient medical record industry(4)
  5. Ehave will enter the $6.38 billion telepsychiatry industry with Active Doctors(4)
  6. Ehave just entered into a licensing agreement to license a complete suite of telemedicine solutions from Activ Doctors Online.(4)
  7. Ehave announced its foray into the growing psychedelics market on December 12 with its KetaDASH platform (Source 14)- an Intravenous (IV) based, home delivery service for patients who have been prescribed KT. The psychedelic drugs market could grow to around $6.85 billion by 2027 at a CAGR of around 16.3%(13)
Source 1: https://www.gminsights.com/industry-analysis/electronic-health-record-market
Source 2: https://www.ehave.com/post/ehaves-dashboard-to-meet-the-challenge-of-electronic-health-records-security-with-burstiq-partnership-utilizing-blockchain-technology
Source 3: https://www.ehave.com/post/ehave-expands-its-psychedelic-mental-health-platform-with-medchart-a-leader-in-medical-record-software-as-a-plugin-to-the-ehave-dashboard
Source 4: https://www.ehave.com/post/ehave-announces-plans-to-enter-the-30-billion-patient-medical-records-industry-and-the-638-billion-telepsychiatry-industry-through-a-licensing-agreement-with-active-doctors
Source 5: https://www.prnewswire.com/news-releases/global-big-data-in-healthcare-market-was-valued-at-over–14-7-billion-in-2018-and-is-projected-to-grow-at-a-cagr-of-around-20-to-reach–42-8-billion-by-2024–300907508.html
Source 6: https://www.prnewswire.com/news-releases/global-electronic-health-records-ehr-market-is-forecast-to-grow-from-an-estimated–30-billion-in-2020-to–40-billion-by-2025-301066044.html
Source 7: https://www.businesswire.com/news/home/20201013005727/en/Global-Big-Data-Healthcare-Market-Growth-Trends
Source 8: https://www.globenewswire.com/fr/news-release/2020/11/09/2122906/0/en/Ehave-s-Dashboard-to-Meet-the-Challenge-of-Electronic-Health-Records-Security-with-BurstIQ-Partnership-Utilizing-Blockchain-Technology.html
Source 9: https://securityboulevard.com/2020/11/u-s-health-care-under-attack/
Source 10: https://www.ehave.com/post/ehave-expands-its-psychedelic-mental-health-platform-with-medchart-a-leader-in-medical-record-software-as-a-plugin-to-the-ehave-dashboard
Source 11: https://www.ehave.com/post/ehave-announces-plans-to-enter-the-30-billion-patient-medical-records-industry-and-the-638-billion-telepsychiatry-industry-through-a-licensing-agreement-with-active-doctors
Source 12: https://www.ehave.com/post/ehave-announces-plans-to-enter-the-30-billion-patient-medical-records-industry-and-the-638-billion-telepsychiatry-industry-through-a-licensing-agreement-with-active-doctors
Source 13: https://www.openpr.com/news/2068844/psychedelic-drugs-market-2020-to-grow-at-16-3-cagr-by-2027
Source 14: https://www.ehave.com/press-releases
Source 15: https://finbox.com/OTCPK:EHVV.F/explorer/marketcap
Source 16: https://finbox.com/OTCPK:EHVV.F/explorer/shares_out
Source 17: https://finbox.com/OTCPK:EHVV.F/explorer/shares_float_pct
Source 18: https://finance.yahoo.com/chart/EHVVF#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-
Source 19: https://finance.yahoo.com/chart/EHVVF#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–
Source 20: https://finance.yahoo.com/chart/EHVVF#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-
Source 21: https://adaa.org/about-adaa/press-room/facts-statistics#:~:text=MDD%20affects%20more%20than%2016.1,older%20in%20a%20given%20year
Source 22: https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2222-4#:~:text=Treatment%2Dresistant%20depression%20(TRD),MDD%20pat

Legal Disclaimer


This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors

We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 1/19/21 and ending on 1/25/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF).

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 1/26/21 and ending on 2/1/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid fifty thousand dollars USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 2/2/21 and ending on 2/8/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid seventy five thousand dollars USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 2/11/21 and ending on 2/17/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid one hundred thousand USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 2/15/21 and ending on 2/19/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid one hundred twenty five thousand USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 2/22/21 and ending on 2/26/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid one hundred fifty thousand USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

Pursuant to an agreement between TD Media LLC and Jonathan D Leinwand LP (We have updated our disclaimer with the proper paying party), TD Media LLC has been hired for a period beginning on 3/1/21 and ending on 3/5/21 to publicly disseminate information about (EHVVF) via digital communications. We have been paid an additional twenty-five thousand USD via bank wire transfer. We own zero shares of (EHVVF). To date we have been paid one hundred seventy-five thousand USD via bank wire transfer to disseminate information about (EHVVF) via digital communications.

INFLUENCER COMPENSATION

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 01/22/2021 and ending on 01/22/2021 to publicly disseminate information about (EHVVF) via digital communications. We have paid this Influencer one thousand five hundred forty five dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 02/03/2021 and ending on 02/03/2021 to publicly disseminate information about (EHVVF) via digital communications. We have paid this Influencer six hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 02/05/2021 and ending on 02/05/2021 to publicly disseminate information about (EHVVF) via digital communications. We have paid this Influencer one thousand two hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 02/22/2021 and ending on 02/22/2021 to publicly disseminate information about (EHVVF) via digital communications. We have paid this Influencer one thousand dollars USD.